World In-vitro Fertilization (IVF) Worth USD 11.3 Billion by 2021 -Opportunities, Technology & Forecasts 2015-2021
Dec 04, 2015, 07:10 ET
DUBLIN, Dec. 04, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/md74lp/world_invitro) has announced the addition of the "World In-vitro Fertilization (IVF) - Market Opportunities and Forecasts, 2014 - 2021" report to their offering.
The global IVF market is expected to reach $11.3 billion by 2021, at a CAGR of 7.0% from 2015 to 2021. Reduction in conception rates mainly in women aged 40 years or above, delayed pregnancy in women suffering from gynecological conditions, changing lifestyle and fertility disorders are the major factors that drive the market growth. Other factors responsible for the market growth are favorable reimbursement scenario and the delayed parenthood opted by couples due to professional and financial constraints. On the other hand, ethical concerns in particular countries, high cost of the IVF procedures and low awareness, especially in under-developed economies such as Nigeria are likely to restrain the market growth.
The rising initiatives towards commercialization of cost-efficient treatments and emerging medical tourism, mainly in developing nations would offer lucrative growth opportunities for IVF service providers in future. Further, the growing clinical research initiatives for the development of novel IVF technologies would provide a platform for growth of the global IVF market.
To provide a detailed market assessment, the report segments the global IVF market on the basis of end-users and geography. The end-users IVF market is categorized into fertility clinics, hospitals, surgical centres and clinical research institutes. Fertility clinics and hospitals were the leading end-user segments globally, accounting for around three-fourths of the market in 2014.
- Cadila Healthcare Ltd.
- Clinica Anglo Americana
- Clinique de la Muette
- Conceptions Reproductive Associates
- Cyprus IVF Center Lifesure Fertility & Gynecology Center
- EMD Serono
- Fertility and Gynecology Center
- Genea Biomedx
- Heidelberg University Hospital
- Klinikum Stuttgart
- LG Lifesciences
- Liv Fertility Center in Puerto Vallarta
- Monterey Bay IVF
- Sun Pharmaceuticals
- The Bridge Center
- Thermo Fisher Scientific Inc.
- Toronto Center for Advanced reproductive Technology Ltd.
- Vitrolife AB.
Chapter: 1 INTRODUCTION
Chapter: 2 EXECUTIVE SUMMARY
Chapter: 3 GLOBAL IN VITRO FERTILIZATION (IVF) MARKET OVERVIEW
Chapter: 4 NORTH-AMERICA IVF MARKET
Chapter: 5 EUROPE IVF MARKET (REVENUE AND NUMBER OF CYCLES)
Chapter: 6 ASIA-PACIFIC IVF MARKET (REVENUE AND NUMBER OF CYCLES)
Chapter: 7 LAMEA IVF MARKET (REVENUE AND NUMBER OF CYCLES
For more information visit http://www.researchandmarkets.com/research/md74lp/world_invitro
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets
Share this article